BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33180318)

  • 1. Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
    He X; Qiu JC; Lu KY; Guo HL; Li L; Jia WW; Ni MM; Liu Y; Xu J; Chen F; Cheng R
    Adv Ther; 2021 Jan; 38(1):607-626. PubMed ID: 33180318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity.
    Kumral A; Tuzun F; Yesilirmak DC; Duman N; Ozkan H
    Acta Paediatr; 2012 Jul; 101(7):e299-303. PubMed ID: 22462821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine Therapy for Apnea of Prematurity: Role of the Circadian
    Guo HL; Long JY; Hu YH; Liu Y; He X; Li L; Xia Y; Ding XS; Chen F; Xu J; Cheng R
    Front Pharmacol; 2021; 12():724145. PubMed ID: 35145399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.
    Puia-Dumitrescu M; Smith PB; Zhao J; Soriano A; Payne EH; Harper B; Bendel-Stenzel E; Moya F; Chhabra R; Ku L; Laughon M; Wade KC;
    J Pediatr; 2019 Aug; 211():27-32.e1. PubMed ID: 31101409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent research on gene polymorphisms related to caffeine therapy in preterm infants with apnea of prematurity].
    Xie JB; Lin XZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):832-837. PubMed ID: 35894202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
    Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
    Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post-marketing study to support paediatric labelling in China.
    Gao XB; Zheng Y; Yang F; Wang CH; Jiang ZH; Wu YE; Jacqz-Aigrain E; Ni SQ; Zhao W
    Br J Clin Pharmacol; 2021 Mar; 87(3):1155-1164. PubMed ID: 32687613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effect of different maintenance doses of caffeine citrate in the treatment of preterm infants requiring assisted ventilation: a pilot multicenter study.
    Yang Y; Lu KY; Cheng R; Zhou Q; Fang GD; Li H; Shao J; Wang HY; Li ZY; Liu SL; Li ZG; Cai JL; Xue M; Chen XQ; Pan ZJ; Gao Y; Huang L; Li HY; Song L; Wang SN; Shu GH; Wu W; Yu MZ; Xu Z; Li HX; Xu Y; Bao ZD; Wu XP; Ye L; Dong XP; Yin QG; Yin XP; Zhou JJ;
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):240-248. PubMed ID: 35351252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms.
    Dai HR; Liu Y; Lu KY; He X; Guo HL; Hu YH; Xu J; Ding XS; Chen F; Cheng R; Jiao Z
    Pharmacol Res; 2022 Oct; 184():106416. PubMed ID: 36029933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
    Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
    Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine citrate: a review of its use in apnoea of prematurity.
    Comer AM; Perry CM; Figgitt DP
    Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic Effects on Systemic Blood Flow and Ductal Shunting Flow after Loading Dose of Intravenous Caffeine in Preterm Infants according to the Patency of Ductus Arteriosus.
    Hwang J; Kim YS; Shin JH; Choi BM
    J Korean Med Sci; 2018 Jan; 33(4):e25. PubMed ID: 29318792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
    Zhang X; Zhang HT; Lyu Y; Wang LF; Yang ZY
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of early caffeine administration and neonatal outcomes in very preterm neonates.
    Lodha A; Seshia M; McMillan DD; Barrington K; Yang J; Lee SK; Shah PS;
    JAMA Pediatr; 2015 Jan; 169(1):33-8. PubMed ID: 25402629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-based differences in apnoea of prematurity: A retrospective cohort study.
    Bairam A; Laflamme N; Drolet C; Piedboeuf B; Shah PS; Kinkead R;
    Exp Physiol; 2018 Oct; 103(10):1403-1411. PubMed ID: 29974527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine citrate for apnea of prematurity-One dose does not fit all a prospective study.
    Rosen C; Taran C; Hanna M; Gueta I; Loebstein R; Strauss T; Yarden-Bilavsky H
    J Perinatol; 2021 Sep; 41(9):2292-2297. PubMed ID: 34290376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and efficacy of caffeine use started at different time in preterm infants: a multicenter study in Jiangsu Province, China].
    Yang Y; Cheng R; Wu Q; Qiao LX; Yang ZM; Gu HB; Jiang SY; Liu SL; Jiang SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Feb; 22(2):130-135. PubMed ID: 32051079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine citrate: when and for how long. A literature review.
    Picone S; Bedetta M; Paolillo P
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():11-4. PubMed ID: 23016611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.